© The EVERY Company The EVERY Company has secured $55 million in a Series D funding round. This funding will support the company’s expansion into the US market as it scales up its production of precision-fermented egg proteins. The round was led by McWin Capital Partners, with participation from a range of investors including Main Sequence, Bloom8, and Minerva Foods. EVERY’s fermentation-based technology has gained significant attention as an alternative to traditional egg proteins. Its ...| vegconomist – the vegan business magazine
Solar Foods, a company specializing in microbial protein production, has created a mayonnaise product using Solein®, a protein derived from air, that replaces| Cultivated X
Molecular farming startup PoLoPo raised funds to develop further its technology that uses potatoes as biofactories to produce animal proteins.| Cultivated X
Precision fermentation company Cauldron Ferm announces it has secured AUD 9.5 million ($6.25M) in a series A round led by Horizons Ventures. SOSV, In-Q-Tel,| Cultivated X
Branded as The EVERY Egg, the innovation is said to match the culinary flexibility of eggs, serving as a 1:1 replacer for mixed eggs in any application,| Cultivated X
